Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Scancell Holdings (SCLP) Share Price

Price 10.00p on 17-11-2025 at 19:35:10
Change 0.00p 0%
Buy 10.30p
Sell 9.70p
Last Trade: Sell 4,600.00 at 9.96p
Day's Volume: 1,122,329
Last Close: 10.00p
Open: 10.00p
ISIN: GB00B63D3314
Day's Range 10.00p - 10.00p
52wk Range: 7.25p - 15.25p
Market Capitalisation: £103.78m
VWAP: 10.10523p
Shares in Issue: 1.04b

Scancell Holdings (SCLP) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 4,600 9.96p Ordinary
14:13:45 - 17-Nov-25
Sell* 7,000 9.95p Ordinary
14:13:02 - 17-Nov-25
Sell* 10,000 9.95p Ordinary
14:11:07 - 17-Nov-25
Sell* 6,000 9.925p Ordinary
12:46:34 - 17-Nov-25
Sell* 2,575 9.911p Ordinary
10:32:50 - 17-Nov-25
Unknown* 250,000 10.10p Negotiated Trade
10:28:08 - 17-Nov-25
Unknown* 19,900 10.00p Ordinary
10:10:47 - 17-Nov-25
Unknown* 500,000 10.14p Negotiated Trade
09:52:41 - 17-Nov-25
Unknown* 150,000 10.09p Ordinary
09:43:28 - 17-Nov-25
Buy* 49,563 10.08p Ordinary
09:05:54 - 17-Nov-25
See more Scancell Holdings trades

Scancell Holdings (SCLP) Share Price History

Time period:
to
Date Open High Low Close Volume
17th Nov 2025 (Mon) 10.00 10.00 10.00 10.00 1,122,329
14th Nov 2025 (Fri) 10.00 10.00 10.00 10.00 519,609
13th Nov 2025 (Thu) 9.95 10.00 9.95 10.00 430,694
12th Nov 2025 (Wed) 9.95 9.95 9.95 9.95 461,593
11th Nov 2025 (Tue) 9.95 9.95 9.95 9.95 234,703
10th Nov 2025 (Mon) 9.76 9.95 9.76 9.95 292,715
7th Nov 2025 (Fri) 9.85 10.40 10.00 10.00 2,252,699
6th Nov 2025 (Thu) 9.85 9.85 9.85 9.85 285,453
5th Nov 2025 (Wed) 9.85 9.85 9.85 9.85 307,390
4th Nov 2025 (Tue) 9.85 9.85 9.85 9.85 110,265
3rd Nov 2025 (Mon) 9.85 9.85 9.85 9.85 398,327
31st Oct 2025 (Fri) 9.65 10.00 9.40 9.85 1,017,329
30th Oct 2025 (Thu) 9.65 9.80 9.65 9.65 164,092
29th Oct 2025 (Wed) 9.65 9.65 9.65 9.65 481,688
28th Oct 2025 (Tue) 9.65 9.65 9.50 9.65 493,270
27th Oct 2025 (Mon) 9.75 10.00 9.65 10.00 4,110,294
24th Oct 2025 (Fri) 9.55 9.75 9.55 9.75 1,102,712
23rd Oct 2025 (Thu) 9.55 9.55 9.55 9.55 62,163
22nd Oct 2025 (Wed) 9.55 9.70 9.55 9.55 348,591
21st Oct 2025 (Tue) 9.55 9.55 9.55 9.55 88,761
20th Oct 2025 (Mon) 9.55 9.55 9.55 9.55 444,527
17th Oct 2025 (Fri) 9.96 9.96 9.10 9.55 326,170
See more Scancell Holdings price history

Scancell Holdings (SCLP) Regulatory News

Date Source Headline
7th Nov 2025 7:00 am RNS Research Update
30th Oct 2025 3:30 pm RNS Result of AGM
3rd Oct 2025 7:00 am RNS Notice of AGM
16th Sep 2025 7:00 am RNS Director Dealing
11th Sep 2025 7:00 am RNS Final Results
4th Sep 2025 7:00 am RNS Notice of Results
8th Aug 2025 12:31 pm RNS Director Dealing
4th Aug 2025 10:23 am RNS Director/PDMR Shareholding
22nd Jul 2025 7:00 am RNS Strong Phase 2 data on iSCIB1+ in Melanoma
16th Jul 2025 7:00 am RNS Share Option Exercise
See more Scancell Holdings regulatory news

Scancell Holdings (SCLP) Share News

UK shareholder meetings calendar - next 7 days

23rd Oct 2025 14:28

Read More

TRADING UPDATES: Gfinity's Yentra partners with ESG Institute

17th Sep 2025 06:55

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Scancell Holdings notes "tough" macro-environment as loss widens

11th Sep 2025 12:06

(Alliance News) - Scancell Holdings PLC on Thursday said it has made "strong progress" over the last 18 months, but noted impacts from the "tough macroeconomic environment", as it posted a wider full-year loss. Read More

TRADING UPDATES: Scancell reports positive data from melanoma trial

23rd Jul 2025 16:47

(Alliance News) - The following is a round-up of updates and earnings by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Scancell partners with NHS to fast-track melanoma vaccine trial

14th Apr 2025 14:02

(Alliance News) - Scancell Holdings PLC on Monday said it has partnered with the NHS Cancer Vaccine Launch Pad, to accelerate patient recruitment into the fourth cohort of its phase 2 scope study for a targeted melanoma vaccine. Read More

See more Scancell Holdings news
FTSE 100 Latest
Value9,675.43
Change-22.94

Login to your account

Forgot Password?

Not Registered